×

Lilly's quarterly checkup: CEO

7:35 AM ET Tue, 26 April 2016

John Lechleiter, Eli Lilly CEO, breaks down the pharma giant's numbers and discusses new products in the pipeline, and provides an update on its diabetes drug, Humalog.